Navigation Links
Spherix to Hold Business Update Conference Call December 9, 2010 at 4:30 p.m. Eastern Time
Date:12/6/2010

BETHESDA, Md., Dec. 6, 2010 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX), an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will host an investment community conference call beginning at 4:30 p.m. Eastern time on Thursday, December 9, to discuss results of the Company's Phase 3 trial with D-tagatose in Type 2 diabetes and to provide a business update.

Investors and other interested parties are invited to listen to the call by dialing (888) 563-6275 from the U.S. or (706) 634-7417 from outside the U.S.  The call also will be available on the Investors section of the Company's website at www.spherix.com.  Slides will accompany the conference call, and will be available in the Investors section of www.spherix.com.

A telephone replay of the conference call will be available for on-demand listening shortly after the completion of the call until 11:59 p.m. Eastern time on December 16, 2010 by dialing (800) 642-1687 from the U.S. or (706) 645-9291 from outside the U.S., and entering access code 29797553.  A replay also will be available at www.spherix.com.

About Spherix

Spherix Incorporated was launched in 1967 as a scientific research company under the name Biospherics Research.  The Company now leverages its scientific and technical expertise and experience through its two subsidiaries – Biospherics Incorporated and Spherix Consulting, Inc.  Biospherics is dedicated to development of D-tagatose and recently completed a Phase 3 clinical trial to study the use of D-tagatose as a treatment
'/>"/>

SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Spherix Receives Nasdaq Letter Extending Minimum Bid Price Compliance Period
2. Spherix Transfers Stock Listing to Nasdaq Capital Market
3. Spherix Reports 3rd Quarter Earnings
4. Spherix Announces 2008 Financial Results
5. Spherix Recruiting New Independent Director to Regain NASDAQ Compliance
6. Spherix Incorporated Announces the Death of A. Paul Cox, Jr., Chairman of the Board
7. Spherix to Exhibit at the BIO 2009 International Convention
8. Spherix Regains Full NASDAQ Compliance
9. Spherix Announces Full-Scale Production of Pharmaceutical Tagatose
10. Spherix Announces Termination of Arla License Agreement
11. Spherix Reports Second Quarter 2009 Earnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)...  Decision Resources Group finds that the majority ... the United States believe that ... be the level of savings achievable by their ... cost to patients. Payers plan to leverage preferential ... expectations in order to encourage physician prescribing of ...
(Date:7/30/2014)... Switzerland (PRWEB) July 30, 2014 ... technologies for biologic drug discovery and mammalian cell line ... SURE CHO-Mplus Libraries ™ will be presented at the ... being held, September 8 – 10, 2014 at ... California. , The following abstract will be presented ...
(Date:7/30/2014)... MA (PRWEB) July 30, 2014 BCC ... Global Markets for Enzymes in Industrial Applications , ... reach to nearly $7.1 billion by 2018, registering a ... growth is estimated to be recorded in the detergent ... forecast period. , Enzyme technology has influenced almost every ...
(Date:7/30/2014)... Md. , July 30, 2014 ... components to interrogate biology, but such devices can ... As such, researchers have looked ... in vitro metabolic engineering to characterize ... a chip. New devices are envisioned to recreate ...
Breaking Biology Technology:Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 2Selexis SA to Present New Data and a Case Study at IBC’s Cell Line Development and Engineering Conference 3Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 2Global Market for Industrial Enzymes to Reach Nearly $7.1 Billion by 2018; Detergent Enzyme Market to Record Maximum Growth 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 2UMD Researchers Bridge Gap between Microelectronics, Biological Systems 3UMD Researchers Bridge Gap between Microelectronics, Biological Systems 4
... Outcomes in Diabetic Patients, NATICK, Mass. and ... BSX ) today announced one-year results,from the ... OLYMPIA,registry. The first 7,124 patient cohort of the ... TAXUS(R) Liberate(TM) coronary stent,system in complex, real-world patients, ...
... A vaccine against anthrax that is more effective and ... effective in tests in mice and guinea pigs, report University ... Infection and Immunity. , The scientists were able to ... the animals noses with a nanoemulsion a suspension of ...
... NASA clean rooms, where scientists and engineers assemble ... deep mines as unlikely places where scientists have ... species of bacteria uncovered in a recent NASA ... According to Dr. Kasthuri Venkateswaran, who led the ...
Cached Biology Technology:Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry 2Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry 3Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry 4Anthrax vaccine produces immunity with nanoparticles, not needles 2Anthrax vaccine produces immunity with nanoparticles, not needles 3NASA study will help stop stowaways to Mars 2
(Date:7/30/2014)... what they eat, the Food and Drug Administration (FDA) ... Facts label found on nearly every food product in ... News (C&EN), the weekly news magazine of the ... the fight that has ensued. , Britt Erickson, a ... Nutrition Facts label has remained largely the same for ...
(Date:7/30/2014)... been awarded the Scientific Committee on Antarctic Research,s ... , SCAR, an inter-disciplinary international science body, initiates, ... in the Antarctic region, and on the role ... The organisation also provides scientific advice about Antarctica ... the region. , The medal is open internationally ...
(Date:7/30/2014)... multitude of cells types. Researchers would like to understand how ... cells that make up the organs and other structures of ... chains of sugars that dangle from proteins on surfaces of ... San Diego, has created synthetic molecules that can stand in ... to direct the process, they report in the Journal ...
Breaking Biology News(10 mins):
... day die from breast cancer in the United States. ... taking hormone replacement therapy to avoid the effects of ... Hyder may lead to treatments for breast cancers associated ... international team, found that hormone-therapy-related breast cancer cells have ...
... extensive joint research project among two American Indian tribes ... A. Fulton Schools of Engineering at Arizona State University ... the Phoenix Metropolitan area has received a national environmental ... was awarded a 2013 National Environmental Excellence Award by ...
... new study raises concerns about possible health impacts of very ... international aid agencies are promoting to replace open-fire cooking in ... Science & Technology . Brian Just and colleagues ... on stoves or open fires that burn wood, animal dung ...
Cached Biology News:Joint air toxics research project among tribes, agencies recognized for partnership 2Joint air toxics research project among tribes, agencies recognized for partnership 3
... V, is used for protein separation and ... system includes both the mini (18 ml) ... harvesting apparatus, cooling finger, electrode chambers, 10 ... syringe, colored protein sample, 2 vent buttons, ...
...
... Labeling Kit - NH2 is primarily used ... immunostaining and cellular proteins for tracing. NH2-Reactive ... succinimidyl group (NHS), and can easily make ... IgG or other proteins without any activation ...
... Lines ,High Quality, Functionally-Validated, Ion Channel Cell ... for having a critical role in nerve ... key function in pain, CNS and the ... been investigated in therapeutic areas, such as ...
Biology Products: